Advancing BioSynthetic Psilocybin & NASDAQ listing reminder We are making moves to get their bio-synthetic psilocybin into production & into vehicles such as a patent pending nasal mist.
Core One produces cGMP/API Pharma grade Psilocybin at 1/100 - 1/1000th of market price.
[url=https://www.globenewswire.com/news-release/2021/04/28/2218305/0/en/Core-One-Labs-to-Explore-Joint-Venture-with-Lobe-Sciences-for-the-Clinical-Development-of-Biosynthetic-Psilocybin.html]https://www.globenewswire.com/news-release/2021/04/28/2218305/0/en/Core-One-Labs-to-Explore-Joint-Venture-with-Lobe-Sciences-for-the-Clinical-Development-of-Biosynthetic-Psilocybin.html[/url]
“ Partnering with Lobe would be an exciting development for the Company as it marks another step towards becoming a viable industry-provider of API grade psilocybin. Additionally, Lobe’s Nasal Mist Device intellectual property would provide the Company access to new patent pending delivery methods and future revenue streams for our biosynthesized psilocybin upon completion of product development and testing stages ,” stated Joel Shacker, CEO of the Company."
Don't forget about our NASDAQ listing.... we could make a move like MMED MNMD has done..... PARABOLIC!!
Repeat: Core One Labs Files Application to List its Common Shares on NASDAQ OTC Markets:CLABF (globenewswire.com)